Johnson & Johnson to spin off orthopedics unit after raising 2025 sales forecast

Core Insights - Johnson & Johnson raised its 2025 revenue guidance following stronger-than-expected third-quarter earnings [1] - The company announced plans to spin off its orthopedics business into a standalone company [1] Financial Performance - The third-quarter earnings exceeded market expectations, contributing to the revised revenue outlook for 2025 [1] Strategic Moves - The decision to spin off the orthopedics business indicates a strategic shift aimed at enhancing focus and operational efficiency [1]